Serán BioScience LLC, a science-driven drug development partner, has completed an expansion to increase the number of process manufacturing suites at its facility in Bend, Oregon, from 6 to 14, adding approximately 130% more cGMP clinical manufacturing capacity. ​ The additional state-of-the-art suites will provide increased flexible capacity for late-stage clinical trial supply for small-molecule medicines. Serán’s ‘Right-From-the-Start’ approach to commercially relevant drug product solution...